Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Eligible age
18+ yrs
Accepts
All genders
Locations
25 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
Sponsor: W.L.Gore & Associates
You may qualify if…
- ✓ 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
- ✓ 2. Patient has been or is intended to be treated with an eligible registry device
- ✓ 3. Patient is age ≥ 18 years at time of informed consent signature.
You may not qualify if…
- ✕ 1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
- ✕ 2. Patient with exclusion criteria required by local law.
- ✕ 3. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.
Where it's recruiting
Little Rock
Irvine · Los Angeles · Palo Alto · Stanford
Miami Beach · Tampa
Atlanta · Augusta · Decatur
Chicago · Evanston
Indianapolis
Louisville
Baton Rouge
Baltimore
Boston
Bay City · Grand Rapids
Minneapolis · Rochester
Source: ClinicalTrials.gov · NCT06218875 · last updated 2026-02-05